HealthTech

ApexSense

ApexSense Raises $10M Series A to Transform HealthTech

$10M Series A
Total Raised
Series
Latest Round
2020
Founded
50-100
Employees
Denver, CO
1 min read

Quick Facts

Valuation
$100M
Latest Round Size
$10M Series A
Latest Round Date
October 2025

ApexSense Raises $10M Series A in Latest Funding Round

ApexSense has successfully closed a $10M Series A funding round, marking a significant milestone in the company's growth trajectory. The round was led by Founders Fund, with participation from Lightspeed Venture Partners.

Company Overview

Founded in 2020 and headquartered in Denver, CO, ApexSense has established itself in the HealthTech space. Leading digital health platform improving patient outcomes through AI-powered diagnostics

With a current valuation of $100M, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $10M Series A
  • Valuation: $100M
  • Lead Investor: Founders Fund

Future Outlook

As ApexSense moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

Founders Fund
Venture Capital
Leading venture capital firm investing in technology companies
Lightspeed Venture Partners
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

Sarah Kim
Sarah Kim
Healthcare and biotech investment analyst with expertise in Series B+ rounds and strategic partnerships.